Topical Delgocitinib Effective for Hand Eczema in Phase 3 Trial ...Middle East

News by : (Medscape) -
The phase 3 study evaluated delgocitinib, an investigational topical pan-JAK inhibitor that inhibits activation of the JAK-STAT pathway and targets key mediators of chronic hand eczema. MDedge News

Read More Details
Finally We wish PressBee provided you with enough information of ( Topical Delgocitinib Effective for Hand Eczema in Phase 3 Trial )

Also on site :

Most Viewed News
جديد الاخبار